Corline Biomedical AB (CLBIO) — Tangible Net Worth Ratio
Corline Biomedical AB (CLBIO) has a Tangible Net Worth Ratio of 20.6% as of December 2025. This metric is calculated by deducting intangible assets (Skr74.43 Million) from net assets (Skr93.76 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Corline Biomedical AB (CLBIO) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Corline Biomedical AB Tangible Net Worth Ratio (2012–2025)
This chart shows how Corline Biomedical AB's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 20.6%, reflecting net assets of Skr93.76 Million with intangible assets of Skr74.43 Million SEK. See CLBIO defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Corline Biomedical AB (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Corline Biomedical AB from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Corline Biomedical AB market capitalisation.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 20.6% | Skr93.76 Million | Skr74.43 Million | Skr98.58 Million | ▲ +5.2 pp |
| 2024 | 15.4% | Skr86.91 Million | Skr73.50 Million | Skr94.76 Million | ▼ -3.1 pp |
| 2023 | 18.6% | Skr93.32 Million | Skr75.99 Million | Skr100.11 Million | ▼ -12.2 pp |
| 2022 | 30.7% | Skr94.59 Million | Skr65.50 Million | Skr101.78 Million | ▼ -7.8 pp |
| 2021 | 38.6% | Skr92.23 Million | Skr56.66 Million | Skr101.66 Million | ▲ +29.8 pp |
| 2020 | 8.8% | Skr52.03 Million | Skr47.47 Million | Skr58.28 Million | ▼ -26.0 pp |
| 2019 | 34.7% | Skr59.32 Million | Skr38.72 Million | Skr63.75 Million | ▼ -3.6 pp |
| 2018 | 38.4% | Skr54.96 Million | Skr33.88 Million | Skr62.91 Million | ▲ +10.2 pp |
| 2017 | 28.2% | Skr45.93 Million | Skr32.98 Million | Skr51.43 Million | ▲ +0.4 pp |
| 2016 | 27.8% | Skr38.75 Million | Skr27.96 Million | Skr41.27 Million | ▼ -68.9 pp |
| 2015 | 96.7% | Skr21.25 Million | Skr695.97K | Skr24.99 Million | ▲ +6.1 pp |
| 2014 | 90.6% | Skr5.48 Million | Skr512.99K | Skr16.77 Million | ▼ -9.4 pp |
| 2013 | 100.0% | Skr8.00 Million | Skr0.00 | Skr13.76 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr1.37 Million | Skr0.00 | Skr12.46 Million | — |